Results 61 to 70 of about 389,128 (274)
Fighting SLAPPS in Federal Court: Erie, the Rules Enabling Act, and the Application of State anti-SLAPP Laws in Federal Diversity Actions [PDF]
, 2015 Legislatures across the United States have passed laws to combat strategic lawsuits against public participation (“SLAPPs”)—suits brought solely to harass a party that has exercised protected speech or petitioning activity.
Ernst, Benjamin
core
Influence of Zn2+ and Oxygen Supply on Malic Acid Production and Growth of Aspergillus oryzae
Biotechnology and Bioengineering, EarlyView.ABSTRACT Malic acid is a valuable platform chemical traditionally derived from fossil‐based resources. Microbial cultivation with Aspergillus oryzae offers a sustainable alternative based on renewable feedstocks. In this study, a well‐established minimal medium for malic acid production, commonly used in previous research to ensure reproducibility, was
Lukas Hartmann +3 more
wiley +1 more source
Protecting the Right of Citizens to Aggregate Small Claims Against Businesses [PDF]
, 2013 Two years ago I ranted against the Supreme Court\u27s subversion of the Rules Enabling Act and its opposition to the benign aims of the twentieth-century progressive law reformers expressed summarily in Rule 1 of our Federal Rules of Civil Procedure.1 I ...
Carrington, Paul D.
core +2 more sources
Biotechnology and Bioengineering, EarlyView.ABSTRACT Protein aggregation poses a significant risk to biopharmaceutical product quality, as even minor amounts of oligomeric species can compromise efficacy and safety. Rapid and reliable detection of protein aggregates thus remains a major challenge in biopharmaceutical manufacturing.
Jakob Heyer‐Müller +4 more
wiley +1 more source
Identity Crisis: Class Certification, Aggregate Proof, and How Rule 23 May Be Self-Defeating the Policy for Which It Was Established [PDF]
, 2011 Class actions suits developed in the United States as a form of “group litigation,” an alternative to the impracticability or inequities of separate, individual actions of a similarly situated class of plaintiffs and, eventually, defendants ...
Whitbeck, J. Britton
core +2 more sources
Biotechnology and Bioengineering, EarlyView.ABSTRACT Multimodal chromatography has emerged as a powerful tool for the purification of monoclonal antibodies (mAbs) and their derivatives—including antibody fragments (Fabs), Fc‐fusions, bispecific (BsAb), and antibody–drug conjugates (ADCs)—offering enhanced selectivity through the integration of ionic, hydrophobic, hydrogen‐bonding, and π–π ...
Amin Javidanbardan +4 more
wiley +1 more source
Enforcement of Forum-Selection Clauses in Federal Court After \u3cem\u3eAtlantic Marine\u3c/em\u3e [PDF]
, 2014 Forum-selection clauses are important agreements that limit exposure to risk of litigation in an undesired locale. The enforcement of forum-selection clauses in the U.S.
Sorensen, Matthew J.
core +1 more source
Transfer Learning Approaches in Bioprocess Engineering: Opportunities and Challenges
Biotechnology and Bioengineering, EarlyView.ABSTRACT Transfer learning (TL) has recently emerged as a promising approach to overcoming one of the key limitations of bioprocess engineering: data scarcity. By leveraging knowledge from one bioprocess to another, TL allows existing models and data sets to be reused efficiently, accelerating process development, improving prediction accuracy, and ...
Daniel Barón Díaz +3 more
wiley +1 more source
Video: Deposition Despots: Managing Difficult Attorneys and Witnesses [PDF]
, 2015 Welcome & Introduction: 7:55 to 8:00 am Elena Rose Minicucci, JD Director, Alumni Relations, NSU Shepard Broad Law Center Welcome Introduce Law Professor Michael Flynn, and attorneys Natalie Giachos, Esq. and Jeremy Singer, Esq.
Flynn, Michael +2 more
core +1 more source
Biotechnology and Bioengineering, EarlyView.ABSTRACT Stem cell‐based therapies hold transformative potential for regenerative medicine, yet their progress is constrained by persistent variability in manufacturing and clinical performance. Conventional frameworks such as Quality by Design (QbD), though effective for drugs and biologics, struggle to accommodate the dynamic nature of living cell ...
Mee‐Hae Kim, Masahiro Kino‐oka
wiley +1 more source